MSI-INDEX · Flagship work

Medicines Security Index

A comparative framework for assessing national capability, exposure and resilience.

Programme purpose

From research to decision capability

The Index will provide a transparent evidence-led methodology for comparing medicines-security conditions without reducing complex national systems to a simplistic league table.

Core workstreams

  • Domain indicators and weighting
  • Country evidence protocol
  • Independent technical review
  • Pilot assessments
OPEN RESEARCH SYSTEMS ↗

Programme status and next steps

Programme development: no validated operational system or country scores are represented.

ILLUSTRATIVE CONTRIBUTOR ROSTER

Suggested contributors · placeholders

All names below are fictional placeholders for programme planning. They will be replaced when contributors are selected; no appointment, affiliation or completed review is implied.

  • Amara Vale — Protocol and evidence lead. Develop the indicator definitions, source requirements and evidence-extraction protocol.
  • Daniel Mercer — Country evidence and data lead. Coordinate evidence collection, provenance checks and country-profile preparation.
  • Leila Rowan — Independent methodology reviewer. Review construct validity, indicator selection and methodological assumptions.
  • Noah Aster — Statistical robustness reviewer. Review weighting, missingness, uncertainty and sensitivity analyses.
  • Maya Ellis — Pilot and review coordinator. Coordinate contributor declarations, pilot responsibilities and review documentation.

Next steps and designated planning roles

  1. Protocol and evidence: Amara Vale and Daniel Mercer to prepare the pilot protocol and evidence requirements.
  2. Contributor selection and conflicts: Maya Ellis to coordinate the replacement of placeholders, participation confirmation and conflict assessments.
  3. Pilot and independent review: Daniel Mercer to coordinate pilot country evidence; Leila Rowan and Noah Aster to review methods and robustness once independence is confirmed.
  4. Reviewed release: Amara Vale and Maya Ellis to prepare outputs for authorised release after independent review, with source dates, uncertainty and explicit evidence limits.

Planning assignments only. Independent validation and validated country scores remain pending.

DRAFT METHODOLOGY AND EVIDENCE PROTOTYPE →
Institutional participation

Partner with MSI-INDEX.

Governments, companies, funders and scholars may commission, support or contribute to this programme.

DISCUSS PARTICIPATION